Jingyang Wu

Quanzhou, 362000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

LncRNA PRKCA-AS1 promotes LUAD progression and function as a ceRNA to regulate S100A16 by sponging miR-508-5p.

LncRNA PRKCA-AS1 promotes LUAD progression and function as a ceRNA to regulate S100A16 by sponging miR-508-5p.

Journal: Journal of Cancer
Published: October 16, 2023

Enumeration and Molecular Characterization of Circulating Tumor Cell Using an Epithelial Cell Adhesion Molecule/Vimentin/Epidermal Growth Factor Receptor Joint Capture System in Lung Cancer.

Enumeration and Molecular Characterization of Circulating Tumor Cell Using an Epithelial Cell Adhesion Molecule/Vimentin/Epidermal Growth Factor Receptor Joint Capture System in Lung Cancer.

Journal: Clinical Medicine Insights. Oncology
Published: August 22, 2023

C1QTNF6 regulated by miR-29a-3p promotes proliferation and migration in stage I lung adenocarcinoma.

C1QTNF6 regulated by miR-29a-3p promotes proliferation and migration in stage I lung adenocarcinoma.

Journal: BMC pulmonary medicine
Published: March 02, 2022

A targeted siRNA-loaded PDL1-exosome and functional evaluation against lung cancer.

A targeted siRNA-loaded PDL1-exosome and functional evaluation against lung cancer.

Journal: Thoracic cancer
Published: January 29, 2022

Identification of a ZC3H12D-regulated competing endogenous RNA network for prognosis of lung adenocarcinoma at single-cell level.

Identification of a ZC3H12D-regulated competing endogenous RNA network for prognosis of lung adenocarcinoma at single-cell level.

Journal: BMC cancer
Published: July 11, 2021

miR-508-5p serves as an anti-oncogene by targeting S100A16 to regulate AKT signaling and epithelial-mesenchymal transition process in lung adenocarcinoma cells.

miR-508-5p serves as an anti-oncogene by targeting S100A16 to regulate AKT signaling and epithelial-mesenchymal transition process in lung adenocarcinoma cells.

Journal: The American journal of the medical sciences
Published: June 22, 2021

Survival outcomes for patients with four treatments in stages I-III esophageal squamous cell carcinoma: a SEER analysis.

Survival outcomes for patients with four treatments in stages I-III esophageal squamous cell carcinoma: a SEER analysis.

Journal: Translational cancer research
Published: October 07, 2020

LncRNA WT1-AS/miR-494-3p Regulates Cell Proliferation, Apoptosis, Migration and Invasion via PTEN/PI3K/AKT Signaling Pathway in Non-Small Cell Lung Cancer.

LncRNA WT1-AS/miR-494-3p Regulates Cell Proliferation, Apoptosis, Migration and Invasion via PTEN/PI3K/AKT Signaling Pathway in Non-Small Cell Lung Cancer.

Journal: OncoTargets and therapy
Published: August 21, 2020

Early diagnosis of lung cancer in the elderly using four tumor markers and serum ferritin for better surgical management.

Early diagnosis of lung cancer in the elderly using four tumor markers and serum ferritin for better surgical management.

Journal: Asian journal of surgery
Published: July 06, 2020

18F-FDG PET-CT metabolic findings can predict the short-term curative effects in esophageal cancer.

18F-FDG PET-CT metabolic findings can predict the short-term curative effects in esophageal cancer.

Journal: International journal of clinical and experimental pathology
Published: August 14, 2019

lncRNA LEF1-AS1 Promotes Malignancy in Non-Small-Cell Lung Cancer by Modulating the miR-489/SOX4 Axis.

lncRNA LEF1-AS1 Promotes Malignancy in Non-Small-Cell Lung Cancer by Modulating the miR-489/SOX4 Axis.

Journal: DNA and cell biology
Published: August 07, 2019
Showing 1-11 of 11

Last Updated: 09/26/2026